Works matching IS 02770008 AND DT 2024 AND VI 44 AND IP 9

Results: 13

Real‐world effectiveness of monoclonal antibody inhibitors of PCSK9 in patients with heterozygous familial hypercholesterolemia: A retrospective cohort study.

Published in:

Pharmacotherapy, 2024, v. 44, n. 9, p. 730, doi. 10.1002/phar.4609

By:

Siemens, Rebecca;
Pryjma, Mark;
Buchkowsky, Susan;
Barry, Arden R.

Publication type:

Article

The power and pitfalls of underpowered studies.

Published in:

Pharmacotherapy, 2024, v. 44, n. 9, p. 698, doi. 10.1002/phar.4605

By:

Carnahan, Ryan M.;
Brown, Grant D.

Publication type:

Article

Physiologically based pharmacokinetic models for predicting lamotrigine exposure and dose optimization in pediatric patients receiving combination therapy with carbamazepine or valproic acid.

Published in:

Pharmacotherapy, 2024, v. 44, n. 9, p. 711, doi. 10.1002/phar.4603

By:

Liu, Zhiwei;
Shao, Wenxin;
Wang, Xingwen;
Geng, Kuo;
Wang, Wenhui;
Li, Yiming;
Chen, Youjun;
Xie, Haitang

Publication type:

Article

Influence of intravenous iron on bacterial infection risk immediately following kidney transplantation.

Published in:

Pharmacotherapy, 2024, v. 44, n. 9, p. 722, doi. 10.1002/phar.4608

By:

January, Spenser E.;
Dubrawka, Casey A.;
Progar, Kristin;
Kurwicki, Karli;
Delos Santos, Rowena

Publication type:

Article

Correction to "Pharmacokinetics/pharmacodynamics analysis and establishment of optimal dosing regimens using unbound cefmetazole concentration for patients infected with Extended‐Spectrum β‐lactamase producing Enterobacterales (ESBL‐E)"

Published in:: Pharmacotherapy, 2024, v. 44, n. 9, p. 760, doi. 10.1002/phar.2927
Publication type:: Article

Incretin hormone agonists: Current and emerging pharmacotherapy for obesity management.

Published in:

Pharmacotherapy, 2024, v. 44, n. 9, p. 738, doi. 10.1002/phar.4607

By:

Alhomoud, Ibrahim S.;
Talasaz, Azita H.;
Chandrasekaran, Preethi;
Brown, Roy;
Mehta, Anurag;
Dixon, Dave L.

Publication type:

Article

The gray area of scientific adequacy.

Published in:

Pharmacotherapy, 2024, v. 44, n. 9, p. 696, doi. 10.1002/phar.4606

By:

DeVane, C. Lindsay

Publication type:

Article

Correction to "International consensus recommendations for the use of prolonged‐infusion beta‐lactam antibiotics: Endorsed by the American College of Clinical Pharmacy, British Society for Antimicrobial Chemotherapy, Cystic Fibrosis Foundation, European Society of Clinical Microbiology and Infectious Diseases, Infectious Diseases Society of America, Society of Critical Care Medicine, and Society of Infectious Diseases Pharmacists"

Published in:: 2024
Publication type:: Correction Notice

Trends in the appropriateness of oral antibiotic prescriptions dispensed in the United States from 2010 to 2018.

Published in:

Pharmacotherapy, 2024, v. 44, n. 9, p. 701, doi. 10.1002/phar.4604

By:

Garg, Mahek;
Venugopalan, Veena;
Vouri, Scott M.;
Diaby, Vakaramoko;
Iovine, Nicole M.;
Wilson, Debbie L.;
Park, Haesuk

Publication type:

Article

ERRATUM.

Published in:: 2024
Publication type:: Correction Notice

Correction to "Risk of incident antidepressant‐treated depression associated with use of 5α‐reductase inhibitors compared with use of α‐blockers in men with benign prostatic hyperplasia: A population‐based study using the Clinical Practice Research Datalink"

Published in:: Pharmacotherapy, 2024, v. 44, n. 9, p. 766, doi. 10.1002/phar.2951
Publication type:: Article

Correction to "Comparative adherence trajectories of oral disease‐modifying agents in multiple sclerosis".

Published in:: Pharmacotherapy, 2024, v. 44, n. 9, p. 753, doi. 10.1002/phar.2846
Publication type:: Article

Issue Information.

Published in:: Pharmacotherapy, 2024, v. 44, n. 9, p. 693, doi. 10.1002/phar.2698
Publication type:: Article